DH41785 0 Posted January 10 Hello! Our lab currently uses Immucor's ImmuAdd for our LISS enhancement. Now, Immucor has discontinued ImmuAdd and has a new product called N-HANCE which is still a LISS enhancement. My question is, do I need to perform a validation or comparison study on the new N-HANCE product when we receive it? Thank you! Share this post Link to post Share on other sites
Townsend 87 Posted January 10 Yes, you should do at least a small parallel study using the old and the new. Your director will have to decide on how many would be acceptable and define acceptability criteria prior to implementation. I would summarize and have them sign-off before placing it into use. 1 David Saikin reacted to this Share this post Link to post Share on other sites
David Saikin 1,336 Posted January 10 N-hance has been around for quite a while. I think it was a Gamma product before Immucor bought them. You should do some validation. Share this post Link to post Share on other sites
